News
Media
PodcastsCase Based Peer PerspectivesInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Paula J. Hillard, MD

Advertisement

Articles by Paula J. Hillard, MD

Practical and straightforward information on LARC

ByPaula J. Hillard, MD
June 18th 2018

Expert commentary on Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.

Advertisement

Latest Updated Articles

  • Practical and straightforward information on LARC
    Practical and straightforward information on LARC

    Published: June 18th 2018 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

FDA clears FemVue Controlled for in-office tubal assessment

2

Michelle Manzo, MPH, CMPP, discusses epilepsy challenges in motherhood

3

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

4

Multidisciplinary initiative boosts iron deficiency screening in pregnancy

5

GSK, Spero Therapeutics resubmits NDA for tebipenem HBr as oral option for complicated urinary tract infections

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us